title: Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
authors.forename: S I
authors.initials: SI
authors.lastname: Blot
authors.forename: E A
authors.initials: EA
authors.lastname: Hoste
authors.forename: K H
authors.initials: KH
authors.lastname: Vandewoude
authors.forename: F A
authors.initials: FA
authors.lastname: Colardyn
mesh_terms: D018806:APACHE; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002177:Candidiasis / Q000188:drug therapy; D016638:Critical Illness; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole